Skip to main content
Premium Trial:

Request an Annual Quote

Psomagen Buys uBiome Assets

This post has been updated to include information from a Psomagen spokesperson.

Microbiome testing firm uBiome, which declared bankruptcy earlier this year, has sold its patents at auction, Stat News reports.

The firm filed for bankruptcy in September and liquidation in October, as GenomeWeb then reported. The Federal Bureau of Investigation launched an inquiry into the firm's billing practices and searched its offices in April. This lead to a shakeup of the firm's management, as its co-founders and co-CEOs were initially placed on administrative leave and then removed, and the suspension of its vaginal and gut microbiome testing programs.

According to Stat News, Psomagen, a Maryland-based subsidiary of the South Korean firm Macrogen, made the only bid for uBiome's assets, though a spokesperson for Psomagen says there were eight bidders. Psomagen, a genetic sequencing company, also sell gut health tests, Stat News notes.

At Korea Biomedical Review, Psomagen says it is acquiring uBiome's assets — including its patents, proprietary data and samples, and lab equipment — for $7.7 million, which it says is about 1 percent of uBiome's enterprise value. It adds that the sale is preliminary and needs to be approved by a bankruptcy court.

"The acquisition is a great maneuver that allows Psomagen to gain global competitiveness and leadership in the microbiome market," Psomagen CEO Ryan Kim tells the Korea Biomedical Review. "The acquisition has given us a key tool to compete in the fierce microbiome market."

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.